13F Filings History of Inspire Advisors, LLC

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$1,086,739,337
Signature - Title
Aaron Moon - Chief Compliance Officer/Investment Adviser Representative
Location
Meridian, ID
Summary
This page shows a list of all the recent 13F filings made by Inspire Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Inspire Advisors, LLC reported 547 stock holdings with total value $1,086,739,337 as of Q4 2025. Top holdings included WWJD, IBD, RISN, PTL, and ISMD.

Follow Filing Activity

Follow Inspire Advisors, LLC and return when a new 13F portfolio filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Holdings Value

Sponsored

Quick Takeaways

  • Inspire Advisors, LLC reports institutional holdings through Form 13F filings.
  • Latest reported quarter: Q4 2025.
  • Latest reported holdings value: $1,086,739,337.

What Changed

  • Most recent filing was accepted on 13 Feb 2026, 16:46.
  • Reported value moved from $1,045,181,451 to $1,086,739,337.

Why This Matters

  • This gives a plain-language read of holdings direction before you open full quarter tables.
  • Use the filing links below to verify the exact SEC source document.

Official SEC Source

Backed by Form 13F

Portfolio holdings and changes are grounded in SEC Form 13F filings.

See Original Filing
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 547 $1,086,739,337 +$153,738,625 -$119,350,938 +$34,387,687 WWJD, IBD, RISN, PTL, ISMD 13F-HR 13 Feb 2026, 16:46
Q3 2025 528 $1,045,181,451 +$107,806,914 -$77,761,854 +$30,045,060 WWJD, RISN, IBD, ISMD, PTL 13F-HR 29 Oct 2025, 12:33
Q2 2025 497 $963,834,650 +$193,784,557 -$138,075,849 +$55,708,708 WWJD, RISN, IBD, ISMD, PTL 13F-HR 11 Aug 2025, 15:32
Q1 2025 449 $865,252,466 +$161,801,858 -$104,206,963 +$57,594,895 WWJD, IBD, RISN, ISMD, PTL 13F-HR 07 May 2025, 12:46
Q4 2024 414 $817,435,634 +$81,143,417 -$66,583,933 +$14,559,484 WWJD, RISN, IBD, ISMD, PTL 13F-HR 07 Feb 2025, 16:42
Q3 2024 423 $822,442,408 +$115,064,368 -$90,422,759 +$24,641,609 WWJD, RISN, IBD, ISMD, PTL 13F-HR 17 Oct 2024, 16:25
Q2 2024 376 $754,201,110 +$208,331,496 -$164,506,949 +$43,824,547 IBD, WWJD, RISN, USFR, ISMD 13F-HR 08 Aug 2024, 16:23
Q1 2024 373 $722,577,093 +$101,592,002 -$70,868,949 +$30,723,053 RISN, IBD, WWJD, BIBL, BLES 13F-HR 07 May 2024, 16:50
Q4 2023 336 $665,464,380 +$141,723,823 -$89,259,387 +$52,464,436 RISN, IBD, WWJD, ISMD, BLES 13F-HR 12 Feb 2024, 14:46
Q3 2023 279 $566,375,975 +$102,765,639 -$36,716,900 +$66,048,739 IBD, RISN, WWJD, USFR, BLES 13F-HR 26 Oct 2023, 11:48
Q2 2023 244 $518,175,817 +$98,277,562 -$27,830,833 +$70,446,729 RISN, IBD, WWJD, BLES, USFR 13F-HR 31 Jul 2023, 10:20
Q1 2023 203 $436,199,837 +$85,746,066 -$53,133,488 +$32,612,578 RISN, IBD, WWJD, USFR, BLES 13F-HR 24 Apr 2023, 10:24
Q4 2022 185 $396,229,723 +$47,164,973 -$32,026,059 +$15,138,914 RISN, IBD, WWJD, BLES, BIBL 13F-HR 26 Jan 2023, 14:28
Q3 2022 156 $364,205,000 +$69,493,740 -$49,876,924 +$19,616,816 RISN, IBD, BLES, WWJD, BIBL 13F-HR 07 Nov 2022, 16:56
Q2 2022 117 $357,492,000 +$90,759,232 -$58,759,474 +$31,999,758 RISN, IBD, USFR, WWJD, BLES 13F-HR 10 Aug 2022, 09:11
Q1 2022 112 $356,224,000 +$77,544,621 -$52,018,036 +$25,526,585 RISN, IBD, VGSH, BLES, WWJD 13F-HR 21 Apr 2022, 10:04
Q4 2021 99 $353,187,000 +$54,270,815 -$13,458,245 +$40,812,570 RISN, IBD, ISMD, BLES, WWJD 13F-HR 02 Feb 2022, 17:32
Q3 2021 91 $317,324,000 +$27,070,537 -$11,806,021 +$15,264,516 RISN, IBD, ISMD, WWJD, BLES 13F-HR 09 Nov 2021, 13:56
Q2 2021 88 $307,151,000 +$30,849,445 -$16,790,494 +$14,058,951 RISN, ISMD, IBD, WWJD, BLES 13F-HR 10 Aug 2021, 16:53
Q1 2021 77 $276,763,000 +$22,425,543 -$29,306,341 -$6,880,798 RISN, ISMD, IBD, WWJD, BLES 13F-HR 30 Apr 2021, 12:23
Q4 2020 781 $267,852,000 $0 $0 $0 RISN, ISMD, IBD, WWJD, BLES 13F-HR 12 Feb 2021, 14:47